Your browser doesn't support javascript.
loading
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.
Parker, H; Rose-Zerilli, M J J; Larrayoz, M; Clifford, R; Edelmann, J; Blakemore, S; Gibson, J; Wang, J; Ljungström, V; Wojdacz, T K; Chaplin, T; Roghanian, A; Davis, Z; Parker, A; Tausch, E; Ntoufa, S; Ramos, S; Robbe, P; Alsolami, R; Steele, A J; Packham, G; Rodríguez-Vicente, A E; Brown, L; McNicholl, F; Forconi, F; Pettitt, A; Hillmen, P; Dyer, M; Cragg, M S; Chelala, C; Oakes, C C; Rosenquist, R; Stamatopoulos, K; Stilgenbauer, S; Knight, S; Schuh, A; Oscier, D G; Strefford, J C.
Afiliación
  • Parker H; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Rose-Zerilli MJ; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Larrayoz M; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Clifford R; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.
  • Edelmann J; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Blakemore S; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Gibson J; Centre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, UK.
  • Wang J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK.
  • Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Wojdacz TK; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Chaplin T; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK.
  • Roghanian A; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Davis Z; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Parker A; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Ntoufa S; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Ramos S; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.
  • Robbe P; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.
  • Alsolami R; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.
  • Steele AJ; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Packham G; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Rodríguez-Vicente AE; Department of Haematology, University Hospital of Salamanca-Biomedical Research Institute of Salamanca, IBMCC, Comprehensive Cancer Center Research, University of Salamanca-CSIC, Salamanca, Spain.
  • Brown L; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • McNicholl F; Department of Haematology, Altnagelvin Area Hospital, Western Health and Social Care Trust, Londonderry, UK.
  • Forconi F; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Pettitt A; Department of Molecular and Clinical Cancer Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • Hillmen P; Department of Haematology, St James's University Hospital, Leeds, UK.
  • Dyer M; College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.
  • Cragg MS; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK.
  • Oakes CC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Knight S; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.
  • Schuh A; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.
  • Oscier DG; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Strefford JC; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
Leukemia ; 30(11): 2179-2186, 2016 11.
Article en En | MEDLINE | ID: mdl-27282254
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / N-Metiltransferasa de Histona-Lisina / Genómica / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / N-Metiltransferasa de Histona-Lisina / Genómica / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido